Skip Ribbon Commands
Skip to main content
SharePoint
 
 
Pharmerit publishes 4-paper series about epidemiology and outcomes of IFI and MRSA in the Middle East
Medical chart review study provides important perspectives on burden of illness and treatment delays in the Africa/Middle East region.
 
Pharmerit publishes cost-effectiveness analysis for treatment of venous thromboembolism with Rivaroxaban
The analysis evaluates health economic consequences of treating venous thromboembolism patients from a Dutch societal perspective
 
Meet the Pharmerit Team at the DIA 2017 Annual Meeting in Chicago
We look forward to seeing you at our booth #2505
 
Conducting rigorous qualitative research with and for patients to provide novel patient-centered perspectives and insights
Pharmerit is proud to be part of the Patient Focused Medicines Development (PFMD) program
 
Optimizing choice of treatment for genotype 1 hepatitis C virus using testing for NS5A resistance
A cost-utility analysis for treatment of hepatitis C from the perspective of the Italian National Health Services

 Latest news

2017-05-30
The analysis evaluates health economic consequences of treating venous thromboembolism patients from a Dutch societal perspective
2017-04-18
Pharmerit is proud to be part of the Patient Focused Medicines Development (PFMD) program

 Our people

“It is very satisfying to work at
a place that truly values and
invests in the professional
growth of its staff„
 
“There is a lot of variety in the work
I do at Pharmerit, which challenges
me to develop myself in different
areas of diseases and different
aspects of health economics.„
 
“Working at Pharmerit is generating
the best evidence, taking into
account clients’ needs and best
research practices„
 
“The fun part is working on
a diverse array of projects
and understanding how
different bits fit together to
form a complete picture„
 
 

 Meet us at

Sep
08
2017
Madrid00:00 - 00:00
Sep
15
2017
Oct
16
2017
Dallas, TX (USA)09:00 - 17:00
Retrieving Data